Healthcare -
Biotechnology - NASDAQ - US
$ 15.135
-2.29 %
$ 1.28 B
Market Cap
-9.34
P/E
Price Target
Average
44.04%
Revenue Forecast
Estimate
181.34%
EBIT
Estimate
--74.42%
Net Income
Estimate
44.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Liquidia Corporation
Wall Street analysts predict an average 1-year price target for LQDA of $21.8 , with forecasts ranging from
a
low of
$17 to a high of $27 .
LQDA Lowest Price Target
Wall Street Target
17 USD
12.32%
LQDA Average Price Target
Wall Street Target
21.8 USD
44.04%
LQDA Highest Price Target
Wall Street Target
27 USD
78.39%
REVENUE FORECAST
Revenue Forecast Chart LQDA
EBIT FORECAST
EBIT Forecast Chart LQDA
NET INCOME FORECAST
Net Income Chart LQDA